Asian cardiology conference proudly announces the asian cardiology congress Primary Health Care and Public Health" which will be held during June 23-24, 2020 Osaka, Japan.
The main objective of Conference is to provide a platform for all the medical professionals including students to discuss and learn the new innovations on cardiology research, clinical updates and new discoveries with the cardiology and industrial experts to advance the ongoing research. The conference will highlight on Cardiac Surgery and Heart Failure, Cardio-Oncology and Resources, Congenital Heart Disease and Pediatric Cardiology, Diabetes and Cardiometabolic Disease, Advanced Lipid Testing, Geriatric Cardiology, Cardiomyopathies, Acute, chronic Heart Failure and Heart Transplant, Interventions and Coronary Artery Disease, Structural Heart Disease, Pulmonary Hypertension, Peripheral Vascular, Noninvasive Imaging, prevention, Sports and Exercise Cardiology, clinical updates, case reports. Cardiology Conference is a unique forum to bring together worldwide distinguished Academics in the field of cardiology, cardiovascular researchers, public health professionals, scientists, academic scientists, industry researchers, scholars to exchange about state of the art research and technologies. Expert faculties will discuss the relevant advances in Cardio research and will explore the novel trends to reduce the effects of cardiovascular risk factors. The aim of this conference is to stimulate new ideas for treatment and analyse the current market for the future direction of cardiovascular drugs, devices, and diagnostics, with an emphasis on newer products that will be beneficial across the spectrum of Cardiology. Lectures will provide a comprehensive state-of-the-art update of the clinical uses of various techniques in the diagnosis, prognosis, and management of common cardiovascular disease
Why to attend:
Asian Cardiology Congress among the World's leading Scientific Conference to bring together worldwide distinguished healthcare experts in the field of cardiology, researchers, public health professionals, professors, academic scientists, industry researchers, scholars to exchange their ideas. You can take the opportunities of lectures from industry leaders, session on hot topics, interaction with company’s representatives, Meeting delegates and interaction over lunch and coffee breaks. The objective of this meeting is to stimulate new ideas for treatment and analyze the current market for the future direction of cardiovascular drugs, devices, and diagnostics, with a greater prominence on newer products that will be beneficial across the spectrum of Cardiology. We expect to welcome healthcare professionals from over 100 countries. We also have global faculty who are leading experts in their fields. Gain valuable awareness from these prominent professionals from skilled institutions.
Growth of Cardiology Market: -
The global cardiac biomarker diagnostic test kits market is expected to be worth US$ 2,540.8 Mn in 2028, and is projected to increase at a CAGR of 5.1% through 2028. North America is expected to be a dominant market, which accounted for US$ 522.5 Mn in 2017, and is expected to grow at a CAGR of 4.3%.
North America has been the dominant regional market for heart diagnostics with a share of approximately 47% of the overall heart diagnostics market in terms of revenue in 2016, followed by Europe which accounted for around 38% share in the market and then by Asia accounting for 15% share.
Governments are trying to limit hospital readmissions to reduce the prevalence of hospital acquired infections (HAIs) by imposing penalties on hospitals. As a result, adoption of home healthcare, remote patient monitoring, and long term care services is rapidly increasing. Thus, demand for cardiovascular devices is increasing from hospitals, patients based in home settings, and long term care centers. In addition, favorable government policies such as reimbursement coverage are fueling adoption of these devices. Thus, increasing target patient population, rising acceptance of home healthcare, and favorable government policies are some of the major factors driving the growth of the global cardiovascular devices market.
On the other hand, high device cost and stringent regulatory approval procedure are some of the prime factors challenging the growth of the market. In addition, lack of skilled professionals to perform surgical procedures using advanced devices is impeding the adoption of new devices. The global cardiac monitoring market is expected to register a CAGR of around 4%. North America accounted for the highest market value in 2017. However, Middle East & Africa is expected to register the highest CAGR during the forecast period. Cardiovascular diseases have become one of the primary reasons for mortality and are becoming a major concern in most parts of the world. Coronary heart disease (CHD) is the most common type of heart disease, with a death toll of more than 370,000 people annually. The American Heart Association (AHA) reports cardiovascular disease to be the leading global cause of death, accounting for 17.3 million deaths per year, a number that is expected to grow to more than 23.6 million by 2030. The Heart Foundation also states that CVD is a major cause of death in Australia, with 45,053 deaths attributed to CVD in the country, in 2014.
Segment 1: ECG Systems| Segment 2: Hoter Monitors Segment
3: Implantable Loop Recorders| Segment 4: Others
Scope and Importance: -
A prospective survey of patients with valvular heart disease (VHD):
-
Coronary angiography was used in 85.2% of patients before intervention.
-
The Euro Heart Survey (EHS) programme has been initiated order to provide quantitative information on cardiovascular disease.
-
To prevent the incidence of cardiovascular (CV) disease, by implementing strategies to reduce the burden of CV risk factors and incidence of CV disease and develop appropriate models for healthy CV lifest